美国众议员 Comer 调查三大 PBM 是否对独立药房进行"惩罚性"审计
STAT+: House lawmaker probes PBMs for ‘punitive’ audits of independent pharmacies
美国众议院监督与政府改革委员会主席 James Comer（R-Ky.）致函 CVS Caremark、OptumRx 和 Express Scripts，调查这三家最大 PBM 是否在独立药房公开支持其去年提出的《Pharmacists Fight Back Act》后，对这些药房发起"负担沉重审计的异常激增"。
By Ed Silverman
Oct. 26, 2026
Pharmalot Columnist, Senior Writer
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter.
A House lawmaker is investigating whether the three largest pharmacy benefit managers targeted independent pharmacies with audits in retaliation for supporting a bill that would require the companies to adjust payments to the retailers.
James Comer (R-Ky.), who heads the House Committee on Oversight and Government Reform, late last week sent letters to CVS Caremark, OptumRx, and Express Scripts, claiming that independent pharmacies “experienced an unusual surge in burdensome audits” after many openly backed the legislation he introduced last year.
Called the Pharmacists Fight Back Act, the bipartisan bill would require pharmacy benefit managers participating in the Federal Employees Health Benefits Program to fairly reimburse pharmacies for the actual cost of medicines and to pay a reasonable fee for dispensing the drugs.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源：STAT News · statnews.com